Literature DB >> 27532302

The Case for a Conservative Approach to Blood Transfusion Management in Cardiac Surgery.

Tyler Gunn1, Gaetano Paone, Robert W Emery, Victor A Ferraris.   

Abstract

Limiting blood transfusion in cardiac operations is a well-meaning goal of perioperative care. Potential benefits include decreasing morbidity and limiting procedural costs. It is difficult to identify transfusion as the cause of adverse outcomes. The need for transfusion may identify a sicker patient population at greater risk for a worse outcome that may or may not be related to the transfusion. We reviewed the indications for and adverse effects of blood transfusion in patients undergoing cardiac procedures to provide a balanced approach to management of blood resources in this population. We reviewed current literature, including systematic reviews and practice guidelines, to synthesize a practice management plan in patients having cardiac operations. Several prospective randomized studies and large population cohort studies compared a postoperative restrictive transfusion policy to a more liberal policy and found very little difference in outcomes but decreased costs with a restrictive policy. Evidence-based practice guidelines and implementation standards provide robust intervention plans that can limit harmful effects of transfusion and provide safe and effective procedure outcomes. A restrictive transfusion policy seems to be safe and effective but does not necessarily provide better outcome in most patient cohorts. The implications of these findings suggest that many discretionary transfusions could be avoided. A subset of high-risk patients could undoubtedly benefit from a more liberal transfusion policy, but the definition of high risk is ill defined.

Entities:  

Mesh:

Year:  2016        PMID: 27532302     DOI: 10.1097/IMI.0000000000000280

Source DB:  PubMed          Journal:  Innovations (Phila)        ISSN: 1556-9845


  2 in total

1.  Implementing a protocol to optimize blood use in a cardiac surgery service: results of a pre-post analysis and the impact of high-volume blood users.

Authors:  Juan B Grau; Jacqueline H Fortier; Cyrus Kuschner; Giovanni Ferrari; Mariano E Brizzio; Alex Zapolanski; Richard E Shaw
Journal:  Transfusion       Date:  2017-07-16       Impact factor: 3.157

2.  Reducing routine laboratory tests in patients with isolated extremity fractures: a prospective safety and feasibility study in 246 patients.

Authors:  Raj M Amin; Alexander E Loeb; Erik A Hasenboehler; Adam S Levin; Greg M Osgood; Robert S Sterling; Philip F Stahel; Babar Shafiq
Journal:  Patient Saf Surg       Date:  2019-06-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.